C. Ronald Kahn

C. Ronald Kahn

academic United States

Dr. C. Ronald Kahn is a prominent professor of medicine at Harvard University and serves as the chief academic officer at Harvard’s Joslin Diabetes Center. He is well-regarded for his research in diabetes and obesity, particularly in understanding the mechanisms of insulin action and resistance. Dr. Kahn has expressed the importance of developing oral weight-loss medications, emphasizing that many patients prefer pills over injections, which aligns with the growing interest in weight-loss treatments like Eli Lilly's orforglipron, a drug recently highlighted for its efficacy in clinical trials.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Australia Australia: Dr. C. Ronald Kahn is a professor of medicine at Harvard University and chief academic officer at Harvard’s Joslin Diabetes Center. 8

The Sydney Morning Herald: Eli Lilly weight-loss pill orforglipron ‘works as well as Ozempic’ in new trial